Facebook Linkedin Mail X Youtube
Facebook Linkedin Mail X Youtube
    Random

    Venous News

    UK’s NICE consults on new draft quality standard for management of...

    Endothermal heat-induced thrombosis after endovenous laser ablation—a rare complication with safe...

    FDA approves Savaysa for reduction of stroke risk in non-valvular atrial...

    UK’s NICE encourages research on percutaneous venoplasty for multiple sclerosis

    Cook Medical launches Zilver Vena Venous Self-Expanding Stent in Canada

    Phase III study investigates cell-based therapy for venous leg ulcers

    Glue is a promising tool in the varicose vein occlusion armamentarium

    FDA grants priority review for rivaroxaban supplemental new drug application for...

    FDA approves Pradaxa for treatment of deep venous thrombosis and pulmonary...

    Authorisation and reimbursement for radiofrequency and endovenous laser ablation across Europe

    Cancer-associated thrombosis patients 35% less likely to experience thromboembolism when treated...

    Vascular Solutions launches reprocessing service for ClosureFAST catheter

    Is all heat the same and does catheter design matter?

    PEARL registry results suggest rheolytic thrombectomy combined with adjunctive therapy is...

    IVUS may be a more accurate method than venography for assessing...

    Thermocoagulation of the great saphenous vein with EVRF is safe and...

    Preliminary data suggest VenaTech convertible filter is a safe and effective...

    The duplex criteria for paediatric reflux testing

    NICE recommends once-daily Lixiana (edoxaban) to treat and prevent adult recurrent...

    New developments in retrievable inferior vena cava filters reviewed

    Satisfactory results with endovenous laser ablation 6.5 years after treatment

    EKOS initiates study in patients with chronic deep vein thrombosis and...

    Bluegrass Vascular Technologies begins first clinical study of the Surfacer Inside-Out...

    FlowAid receives FDA US market clearance for the FA100 SCCD

    BTG launch Varithena in Canada

    Bioconvertible inferior vena cava filter could eliminate retrieval and complications

    Option Elite retrievable vena cava filter receives FDA clearance for a...

    NICE publishes final guidance on the use of Eliquis (apixaban) to...

    Percutaneous endovenous intervention effective for upper extremity deep venous thrombosis

    Screening can significantly reduce number of venous thromboembolism deaths

    Hybrid operative thrombectomy is non-inferior to percutaneous techniques for acute iliofemoral...

    Recurrence after ablation for varicose veins associated with perforating veins

    Volcano Corporation to acquire Crux Biomedical

    FDA clears NeverTouch Direct Procedure Kit to treat varicose veins

    Study based on “real world” US database sheds light on inferior...

    Sapheon submits second module of PMA application for VenaSeal Sapheon Closure...

    FDA clears first ever bi-directionally retrievable vena cava filter from Crux...

    Health Canada approves polidocanol injectable foam for patients with varicose veins

    BTG receives FDA 510(k) clearance for EKOS Control Unit 4.0

    Mechanochemical ablation shows 96% closure rate at two years

    Varithena earns FDA approval for 30-day post-activation shelf life

    ASPIRE trial shows 34% reduction in major vascular events with aspirin...

    FDA IDE approval for Veniti Vici venous stent system

    Treatment of superficial vein thrombosis with intermediate doses of tinzaparin

    Veniti announces first uses of Veniti Vici Venous Stent System

    No evidence to support placement of filters in patients undergoing bariatric...

    A record-breaking week for the CX Venous Workshop

    Edoxaban significantly reduces risk of venous thromboembolism by half compared to...

    Cook Medical begins two studies on inferior vena cava filters

    Eliquis (apixaban) receives CHMP positive opinion for the treatment of deep...

    One-year data of the Sapheon Closure system trial show positive results

    Covidien launches campaign to increase awareness of pregnancy-related blood clots

    Intrinsic Imaging awarded interventional medical device trial for prevention of pulmonary...

    FDA classifies Covidien field action for Trellis-6 and Trellis-8 systems as...

    “IVUS should be the gold standard for diagnosing and directing treatment...

    cyanoacrylate adhesive perforator embolisation

    Cyanoacrylate adhesive perforator embolisation successful while avoiding risk of “inadvertent thermal...

    ALN launches Vena Cava Filter with Hook in the USA

    VenaSeal closure system demonstrates long-term durability and improved quality of life...

    Lymphoedema management: A collaborative approach for patients and clinicians

    AMPLIFY data indicate Eliquis (apixaban) is comparable to conventional therapy in...

    Saphenous pulsation on duplex ultrasound is a marker of severe chronic...

    Endovenous laser therapy of saphenous vein reflux using thulium laser with...

    Stryker launches Restep deep vein thrombosis compression sleeve

    Pelvic vein reflux could cause haemorrhoids, study suggests

    Evidence for deep venous reconstruction is “extremely weak”

    FDA approves polidocanol injectable foam for varicose veins

    Global clinical study initiated to determine safety and effectiveness of stent...

    Treating cutaneous ulcers with human skin wound dressings

    Radiofrequency ablation effective in the treatment of large diameter varicose veins...

    CE mark granted to FlowAid Medical FA100 sequential contraction compression device

    Rivaroxaban recommended for approval for pulmonary embolism in Europe

    New anticoagulant edoxaban shows less bleeding than warfarin in Hokusai-VTE

    Intravascular ultrasound in venous disease

    Two new real-world studies confirm positive efficacy and safety profile of...

    Scottish Medicines Consortium accepts rivaroxaban for NHS use in two new...

    Canadian study suggests no link between venous stenosis and multiple sclerosis

    Long-term outcomes of percutaneous mechanical thrombectomy for severe pulmonary embolism

    Early data from venous stent trials “very promising”

    Veniti closes on US$25m from Boston Scientific

    European commission approves rivaroxaban for the treatment of pulmonary embolism and...

    ULTIMA trial results published in Circulation

    Tactile Medical launches wound care product to treat venous leg ulcers

    Nobilis Health acquires Hamilton Vein Center

    LeMaitre Vascular acquires InaVein

    Key clinical questions I would like to see answered in the...

    VeClose trial indicates 24-month non-inferiority of VenaSeal versus radiofrequency ablation

    Rivaroxaban shows comparable efficacy to standard of care for pulmonary embolism...

    Venography and IVUS for the diagnosis and treatment of iliofemoral venous...

    FDA expands use of rivaroxaban to treat deep vein thrombosis or...

    Real world ETNA registries of new once-daily edoxaban commence in Europe

    Dedicated endovenous stents effective to relieve outflow obstruction at one year

    Crux Biomedical’s inferior vena cava filter receives CE mark

    Computerised checklist offers best preventive strategy for venous thromboembolism

    A novel method of oedema fluid drainage in obstructive lymphoedema

    biolitec introduces new Leonardo Mini multi-function laser

    New varicose vein treatment available in Europe

    New drug application for edoxaban submitted in Japan

    Multicentre study evaluates method to improve retrieval rate of inferior vena...

    Pradaxa gains EU approval

    European Commission approves Eliquis (apixaban) for treatment of deep vein thrombosis...

    Edoxaban approved for prevention of stroke and systemic embolism in non-valvular...

    New segmental venous stent shows superior patency rates in occlusive disease

    Angel Catheter is CE-marked

    94% closure rate of varicose veins after one year with VenaSeal...

    Delegates benefit from hands-on training and learning at the CX Office-based...

    Studies support benefit of dabigatran for prevention of recurrent deep vein...

    Final patient enrolled for iliofemoral venous stent study

    Tulip fibre shows reduced side-effects in great saphenous vein ablation

    New rotational pharmacomechanical thrombectomy device promising for deep vein thrombosis

    Lawrence Livermore National Lab and Near Infrared Imaging release Vein-Eye camera

    Secondary analysis of AMPLIFY-EXT examining predictors of hospitalisation presented at ESC...

    Ultrasound-enhanced catheter-directed thrombolysis as the standard of care for acute DVT

    Sapheon completes enrolment in US pivotal study of VenaSeal

    EVRF system trial shows 96.8% complete occlusion at three years

    Catheter-directed thrombolysis reduces risk of post-thrombotic syndrome in patients with DVT...

    Ultrasound-accelerated thrombolysis shows advantage over anticoagulation alone in submassive pulmonary embolism

    Edoxaban evaluated in two subgroup analyses of East Asian patients from...

    US FDA grants 510(k) clearance to Teleflex for Arrow VPS Rhythm...

    The success of deep venous intervention rests on mid- to long-term...

    PREFER in VTE European registry enrols first patient

    NICE clinical guideline set to save lives by improving the diagnosis...

    Five-year results from the ClosureFast long-term European multicentre study announced

    More bleeding with catheter-directed thrombolysis than with standard anticoagulation in deep...

    Covidien launches next generation Trellis peripheral infusion system

    NICE UK draft guidance recommends rivaroxaban for pulmonary embolism

    Offer less invasive treatments before surgery for varicose veins, says UK...

    Assessing the outcomes of venous interventions

    CX Venous Workshop draws in the crowds

    Phase III study of dabigatran meets primary endpoint for six-month treatment...

    VeClose trial reports “excellent” clinical and quality of life outcomes at...

    mechanochemical ablation

    MOCA effective for greater saphenous vein insufficiency out to three years

    Most read

    Features

    Profiles

    Anahita Dua

    Kak Khee Yeung

    Marianne Brodmann

    Vascular News

    Write to us
    Editor: Jocelyn Hudson jocelyn@bibamedical.com
    Advertising: Nathalie Fortin nathalie@bibamedical.com


    BIBA Medical, Europe
    526 Fulham Road, Fulham, London, SW6 5NR
    TEL: +44 (0)20 7736 8788
    Email: info@bibamedical.com

    Terms and Conditions | Privacy Policy
    Facebook Linkedin Mail X Youtube